Aehr Test Systems filings document material events, operating results, capital actions and governance matters for a semiconductor test and burn-in equipment company. Recent Form 8-K disclosures include quarterly financial-result releases covering revenue, bookings, backlog, cash position and GAAP and non-GAAP earnings measures.
The filing record also includes capital-structure disclosures tied to an at-the-market common stock offering under a Form S-3 registration statement, along with proxy and annual meeting materials. Those governance filings address director elections, shareholder voting results, amendments to the company’s equity incentive and employee stock purchase plans, auditor ratification and executive-compensation matters.
AEHR TEST SYSTEMS Chief Operating Officer Adil Engineer reported a same-day option exercise and sale sequence. He exercised options to acquire 15,000 shares of common stock at an exercise price of $9.45 per share, then sold 7,500 shares at $130.9549 and another 7,500 shares at $131.0950 per share. Following the derivative exercises, he reported remaining direct option holdings of 31,330 and 28,088 options in the respective grants. One reported amount of common stock includes shares subject to unvested restricted stock units.
Aehr Test Systems director Laura Oliphant reported a sale of 1,717 shares of Common Stock on 2026-08-12 in an open market or private transaction at $133.00 per share. Following this transaction, she reported holding 16,100 shares, which the company notes include shares subject to unvested restricted stock units.
A holder of AEHR common stock filed a notice of intent to sell shares. The planned transaction covers 9,672 shares of common stock to be sold through Fidelity Brokerage Services LLC on August 13, 2026 on NASDAQ, with an aggregate market value of $1,235,287.65. The shares to be sold were originally acquired in several transactions, including 7,200 shares obtained in a merger for cash on August 1, 2024, and restricted stock that vested as compensation in lots of 2,091 shares on July 2, 2025 and 381 shares on August 1, 2025.
The Caroline J. Scott Revocable Trust Agreement intends to sell up to 20,000 shares of AEHR common stock through Fidelity Brokerage Services, with an aggregate market value of $2,630,305.62, on or after August 12, 2026 on NASDAQ. These shares were acquired in a private placement from the issuer on December 18, 2015 for cash. The trust also reports that 20,000 shares of common stock were sold on July 16, 2026 for $1,642,649.44.
An affiliate of AEHR filed a notice of proposed sale of restricted shares. The filing lists 1,717 shares of common stock to be sold through Fidelity Brokerage Services LLC on NASDAQ, with an aggregate market value of $228,361.17 and a proposed sale date of 08/12/2026.
The securities to be sold originated from restricted stock vesting awards treated as compensation, including 1,159 shares vesting on 07/11/2025 and 558 shares vesting on 07/27/2025.
Aehr Test Systems (AEHR) filed a notice of proposed sale under Rule 144 for up to 40,000 shares of common stock to be sold through Fidelity Brokerage Services LLC on 08/12/2026 on NASDAQ, with an aggregate market value of $5,233,716.34. The filing also lists prior issuances of common stock as compensation via restricted stock vesting on several dates in 2021 and 2022, including 28,168 shares on 08/13/2021, 2,082 shares on 04/01/2022, 5,489 shares on 04/20/2022, 2,044 shares on 07/13/2022, and 2,217 shares on 10/03/2022.
AEHR TEST SYSTEMS executive Alistair N. Sporck, VP Contactor Business Unit, reported selling 1,000 shares of common stock on 2026-08-10 at $108.49 per share. After the sale, he holds 22,547 directly (including unvested restricted stock units) and 5,177 shares indirectly through a trust.
AEHR insider Alistair N. Sporck filed a notice to sell 1,000 shares of common stock through Fidelity Brokerage Services on NASDAQ on or after 08/10/2026. The filing also lists 1,000 shares from restricted stock vesting on 07/01/2026 as compensation and discloses a prior sale of 2,000 shares for $201,916.91 on 08/04/2026 within the last three months.